Search filters

List of works by Zoe Moodie

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

scientific article

A New Framework for Nonparametric Estimation of the Bivariate Survivor Function ⬇️

doctoral thesis by Felicity Zoe Moodie, University of Washington, 2001

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

scientific article (publication date: 2011)

An adjustment to improve the bivariate survivor function repaired NPMLE

scientific article published on 01 September 2005

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

scientific article published on 22 May 2020

Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus

scientific article published on 20 March 2020

Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response

scientific article published on 01 July 2019

Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults

scientific article published on 17 October 2019

Comparing and combining data across multiple sources via integration of paired‐sample data to correct for measurement error ⬇️

scientific article published on July 5, 2012

Comparison of Sexual Behavior and HIV Risk between Two HIV-1 Serodiscordant Couple Cohorts: The CHAVI 002 Study ⬇️

scientific article published on May 22, 2012

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.

scientific article published on 14 September 2015

Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals

scientific article

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? ⬇️

scientific article published on January 29, 2013

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

scientific article

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy

scientific article published on 13 June 2018

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection

scientific article published on 29 January 2020

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

scientific article published on 2 September 2015

Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop

scientific article published on January 2007

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

scientific article published on 07 February 2020

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

scientific article

Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial

scientific article published on 04 November 2020

Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study

scientific article

Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries

scientific article published on 28 December 2020

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines ⬇️

scientific article published on December 1, 2003

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans

scientific article published on 30 January 2020

Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America

scientific article published on 15 June 2020

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

scientific article published on 13 September 2012

Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America

scientific article published on 01 February 2018

New clinical trial designs for HIV vaccine evaluation

scientific article published on September 2013

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

scientific article published on 3 April 2007

Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study

scientific article published on 15 January 2014

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

scientific article

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa.

scientific article

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

article

P16-42. Characterisation of HIV-1 specific T-cell responses in exposed uninfected individuals from a London cohort

scientific article

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease

scientific article published in PLoS ONE

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

scientific article published on 8 November 2006

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

scientific article published on 8 November 2006

Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials

scientific article published on 10 February 2016

Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners

scientific article published on 12 June 2013

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

scientific article

Response Determination Criteria for ELISPOT: Toward a Standard that Can Be Applied Across Laboratories ⬇️

scientific article published on 01 January 2012

Response definition criteria for ELISPOT assays revisited

scientific article

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

scientific article

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

scientific article published on 24 February 2020

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)

scientific article

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals

scientific article published on 7 November 2006

Self-reported Benefits of Study Participation in HVTN 503, “Phambili”.

scientific article published in October 2014

Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials

scientific article published on 29 November 2021

Statistical evaluation of HIV vaccines in early clinical trials.

scientific article

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

scientific article published on 15 August 2006

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.

scientific article

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083

scientific article

Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells

scientific article published on 27 November 2019

Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype

scientific article

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

scientific article

Paulina is supported by:

About Paulina

Help